IQVIA Holdings Inc. (IQV)
| Market Cap | 46.03B |
| Revenue (ttm) | 13.54B |
| Net Income (ttm) | 767.00M |
| Shares Out | 191.04M |
| EPS (ttm) | 3.93 |
| PE Ratio | 61.33 |
| Forward PE | 24.21 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,108,070 |
| Open | 245.00 |
| Previous Close | 244.40 |
| Day's Range | 239.85 - 248.25 |
| 52-Week Range | 170.00 - 285.61 |
| Beta | 1.41 |
| Analysts | Strong Buy |
| Price Target | 304.28 (+26.3%) |
| Earnings Date | Feb 8, 2022 |
About IQV
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and dissemin...
Financial Performance
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for IQVIA Holdings stock is "Strong Buy." The 12-month stock price forecast is 304.28, which is an increase of 26.28% from the latest price.
News
IQVIA Holdings (IQV) Stock Up 34.4% In a Year: Here's Why
Consecutive better-than-expected top- and bottom-line performances and shareholder-friendly moves have been aiding IQVIA Holdings (IQV) stock.
Oppenheimer healthcare strategist on why he likes the CRO space in 2022
Jared Holz, Oppenheimer healthcare strategist, joins 'Power Lunch' to discuss the healthcare sector and why biotech companies could struggle the most in the space. For access to live and exclusive video...
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
IQVIA's (IQV) growing client base is a result of the company's ability to standardize, organize and integrate its enormous treasure trove of data.
Tired of Metaverse Mania? 3 Growth Stocks That Are Great Buys Right Now
Been missing out on other hot growth trends? Get real.
Global Medicine Spending to Reach $1.8 Trillion in 2026, Including Spending on COVID-19 Vaccines, According to Study ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Global spending on medicines — based on invoice price levels — is expected to grow at 3-6% CAGR through 2026 to reach about $1.8 trillion by 2026, includin...
IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Services Unit
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is l...
3 Technology Services Stocks to Watch Despite Industry Challenges
The Zacks Technology Services industry is likely to benefit from COVID-19-driven dependency on technology, increased digitization and adoption of the multi-cloud model. IQV, STX and BCOR are well positi...
IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, was ...
IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engagement Platform
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announ...
IQVIA (IQV) Riding on Global IT Infrastructure, Debt Woe Stays
IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.
IQVIA (IQV) Beats on Q3 Earnings & Revenues, Raises 2021 View
IQVIA's (IQV) third-quarter 2021 earnings and revenues increase year over year.
IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates
IQVIA (IQV) delivered earnings and revenue surprises of 1.88% and 0.99%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
IQVIA Holdings' Beat On Q3 Earnings, Raises FY21 Outlook
IQVIA Holdings Inc (NYSE: IQV) has posted Q3 adjusted EPS of $2.17, up 33% Y/Y, marginally surpassing the consensus of $2.12 Revenue of $3.4 billion increased 21.7% on a reported basis and 21.1 percent ...
IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the lif...
Why IQVIA Holdings (IQV) Might Surprise This Earnings Season
IQVIA Holdings (IQV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for IQVIA Holdings (IQV) in Q3 Earnings?
IQVIA's (IQV) third-quarter 2021 earnings and revenues are expected to have improved year over year.
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Q3 Release
IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA to Announce Third-Quarter 2021 Results on October 21, 2021
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2021 financial results before the market opens on Thursday, October 21, 2021. The ...
IQVIA to Host Financial Analyst and Investor Conference on November 16, 2021
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will host an Analyst and Investor Conference in New York City on Tuesday, November 16, 2021. Management will prov...
IQVIA Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announce...
Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Salesforce Productivity
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced...
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
Solid shareholder-friendly measures and strong healthcare-specific global IT infrastructure boost IQVIA Holdings (IQV) shares.
IQVIA Holdings' (IQV) Stock Up 44% Year to Date: Here's Why
Encouraging yearly guidance and consecutive better-than-expected top- and bottom-line performances have been aiding IQVIA Holdings' (IQV) stock.
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, toda...
IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) announces its strategic collaboration with HealthCore, Inc., a leading real world research organization in the United States, to advance...